Allogene cuts 22% of workforce amid blood cancer therapy pivot
While also announcing a partnership with Foresight Diagnostics, Allogene will focus cema-cel’s use as a first-line consolidation therapy in lymphoma patients.
08 January 2024
08 January 2024
While also announcing a partnership with Foresight Diagnostics, Allogene will focus cema-cel’s use as a first-line consolidation therapy in lymphoma patients.
Last week, the FDA’s Safer Technologies Program (STeP) accepted EndoQuest's flexible surgical robotic system.
The Cordella system aims to enhance the management of heart failure (HF) patients by providing proactive pulmonary artery pressure data.
The company has made moves to expand its market by partnering with Hikma Pharmaceuticals to expand across the region.
The soft robotic wearable device is designed to help eliminate freezing, a symptom that often leads to falls.
The Micra AV2 and VR2 leadless pacemakers offer patients up to 17 years of battery life and remote monitoring capabilities.
The Grappler Knotless Anchor System and Bridgeline Tape expand the company’s foot and ankle soft tissue product range.
GlobalData predicts that the major technology themes expected to influence the medical device industry in 2024 are AI, cybersecurity, robotics, AI regulation, and digitalization. Furthermore, remote patient monitoring and precision medicine have been identified as the major industry themes set to shape the the medical devices market in 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Give your business an edge with our leading industry insights.